Role of Intrauterine Insemination in Patients With Endometriosis I-II
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03425604 |
Recruitment Status :
Completed
First Posted : February 7, 2018
Last Update Posted : February 12, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Endometriosis I-II | Procedure: Intrauterine insemination |
Study Type : | Observational |
Actual Enrollment : | 9979 participants |
Observational Model: | Case-Control |
Time Perspective: | Retrospective |
Official Title: | Role of Intrauterine Insemination in Patients With Endometriosis I-II |
Actual Study Start Date : | January 2011 |
Actual Primary Completion Date : | January 2017 |
Actual Study Completion Date : | June 2017 |

Group/Cohort | Intervention/treatment |
---|---|
Endometriosis I y II, according to ASRM classification
Cycles were chosen for analysis only when all the following selection criteria were satisfied: < 38 years old women, antral follicle count > 6, basal FSH < 10mUI/ml, BMI<30, Infertility time <4 years, absence of uterine malformations, endometrial polyps or myomas, absence of known thrombofilia, normal kayotype, < 3 previous IUI cycles, no male severe factor associated
|
Procedure: Intrauterine insemination |
patients without endometriosis
Cycles were chosen for analysis only when all the following selection criteria were satisfied: < 38 years old women, antral follicle count > 6, basal FSH < 10mUI/ml, BMI<30, Infertility time <4 years, absence of uterine malformations, endometrial polyps or myomas, absence of known thrombofilia, normal kayotype, < 3 previous IUI cycles, no male severe factor associated
|
Procedure: Intrauterine insemination |
- pregnancy rate [ Time Frame: 2011-2017 ]to compare pregnancy rate between Endometriosis I-II patients (according to ASRM classification) vs. control group (patients without endometriosis) going under an IUI cycle

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 38 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:< 38 years old women, antral follicle count > 6, basal FSH < 10mUI/ml, BMI<30, Infertility time <4 years, absence of uterine malformations, endometrial polyps or myomas, absence of known thrombofilia, normal kayotype, < 3 previous IUI cycles, no male severe factor associated
-
Exclusion Criteria:
- > 38 years old
Responsible Party: | IVI Bilbao |
ClinicalTrials.gov Identifier: | NCT03425604 |
Other Study ID Numbers: |
IVIBILBAO |
First Posted: | February 7, 2018 Key Record Dates |
Last Update Posted: | February 12, 2020 |
Last Verified: | February 2018 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Endometriosis |